LabLogic, a leading provider of drug metabolism LIMS and radiochromatography solutions, announced that Charles River has upgraded to Debra version 5.7.10 for its radiolabelled mammalian metabolism and environmental fate studies. Charles River has been using LabLogic’s software for over 13 years for the management of all chemicals and pharmaceutical ADME studies. This upgrade follows on from the recent upgrade of the chromatographic system Laura to version 4.1.4.
Geoff Burns, Director of Laboratory Sciences at Charles River Edinburgh, commented “Integration of total radioactivity data with metabolite profiling is key in the characterization of the disposition of drugs and chemicals. These LIMS upgrades allow us to offer additional efficiency and flexibility to our customers worldwide by providing an identical global platform to our preclinical teams in Montreal and Edinburgh.”
Huw Loaring, Systems Director at LabLogic added “We have had a long partnership with Charles River and we are very pleased to see them upgrade to utilise the latest technology that LabLogic have to offer. In particular, Charles River will now be looking to implement the Protein Binding module in Edinburgh which will allow improved data handling of these assays.”
Date: May 29, 2012
Source: LabLogic https://www.lablogic.com
Filed Under: Drug Discovery
